NYSE:HUM - New York Stock Exchange, Inc. - US4448591028 - Common Stock - Currency: USD
255.91
-15.39 (-5.67%)
The current stock price of HUM is 255.91 USD. In the past month the price decreased by -12.9%. In the past year, price decreased by -29.48%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UNH | UNITEDHEALTH GROUP INC | 16.71 | 429.24B | ||
ELV | ELEVANCE HEALTH INC | 11.68 | 89.31B | ||
CNC | CENTENE CORP | 8.12 | 28.60B | ||
MOH | MOLINA HEALTHCARE INC | 12.53 | 15.75B | ||
HQY | HEALTHEQUITY INC | 35.37 | 9.41B | ||
ALHC | ALIGNMENT HEALTHCARE INC | N/A | 2.53B | ||
CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 2.20B | ||
PGNY | PROGYNY INC | 40 | 1.98B | ||
NEUE | NEUEHEALTH INC | 5.57 | 60.93M |
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,600 full-time employees. The company operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. The company also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. The company also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. The company also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.
HUMANA INC
500 W Main St
Louisville KENTUCKY 40202 US
CEO: Bruce D. Broussard
Employees: 67600
Company Website: https://www.humana.com/
Investor Relations: https://humana.gcs-web.com/
Phone: 15025801000
The current stock price of HUM is 255.91 USD. The price decreased by -5.67% in the last trading session.
The exchange symbol of HUMANA INC is HUM and it is listed on the New York Stock Exchange, Inc. exchange.
HUM stock is listed on the New York Stock Exchange, Inc. exchange.
31 analysts have analysed HUM and the average price target is 298.52 USD. This implies a price increase of 16.65% is expected in the next year compared to the current price of 255.91. Check the HUMANA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HUMANA INC (HUM) has a market capitalization of 30.87B USD. This makes HUM a Large Cap stock.
HUMANA INC (HUM) currently has 67600 employees.
HUMANA INC (HUM) has a support level at 255.38 and a resistance level at 271.08. Check the full technical report for a detailed analysis of HUM support and resistance levels.
The Revenue of HUMANA INC (HUM) is expected to grow by 6.43% in the next year. Check the estimates tab for more information on the HUM EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HUMANA INC (HUM) has a dividend yield of 1.38%. The yearly dividend amount is currently 3.55. Check the full fundamental report for a detailed analysis of HUM dividend history, reliability and sustainability.
HUMANA INC (HUM) will report earnings on 2025-04-22, after the market close.
The PE ratio for HUMANA INC (HUM) is 15.81. This is based on the reported non-GAAP earnings per share of 16.19 and the current share price of 255.91 USD. Check the full fundamental report for a full analysis of the valuation metrics for HUM.
The outstanding short interest for HUMANA INC (HUM) is 3.81% of its float. Check the ownership tab for more information on the HUM short interest.
ChartMill assigns a fundamental rating of 4 / 10 to HUM. HUM has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months HUM reported a non-GAAP Earnings per Share(EPS) of 16.19. The EPS decreased by -37.71% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.02% | ||
ROA | 2.6% | ||
ROE | 7.37% | ||
Debt/Equity | 0.72 |
ChartMill assigns a Buy % Consensus number of 69% to HUM. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of 2.39% and a revenue growth 6.43% for HUM